# ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer

> **NCT01242605** · PHASE1 · COMPLETED · sponsor: **University College, London** · enrollment: 13 (actual)

## Conditions studied

- Biliary Tract Neoplasms
- Cholangiocarcinoma
- Gallbladder Neoplasms

## Interventions

- **DRUG:** selumetinib
- **DRUG:** gemcitabine
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT01242605
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-03
- **Final completion:** 2016-05
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2016-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01242605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01242605, "ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01242605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*